(Axios) – A rash of generic drug shortages across the United States can be partly explained by a somewhat counterintuitive and politically inconvenient factor: The prices are way too low. Why it matters: Proposals for addressing the complex factors driving the scarcity wouldn’t come cheap, and that’s especially true of the politically popular push to make more drugs in America. (Read More)